Effect of an Ayurvedic treatment modality Madutailika Basti (therapeutic enema) in bringing back the normalcy of low back ache patients in terms of a particular enzyme(Angiotensin converting enzyme)

Effect of Madutailika Basti in Renin-Angiotensin System W.S.R to Angiotensin Converting Enzyme in Katigraha-A Randomized Controlled Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025366

Enrollment

100

Registered

2020-05-26

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: sarvanga abhyanga, anulomana with eranda taila, madutalika basti and rasna guggulu: sarvanga abhyanga with bala taila and bhaspa sweda for 3 days, anulomana with eranda taila (30-70ml)

Eligibility

Inclusion criteria

Inclusion criteria: Patients indicated for basti karma. Patients willing to sign the consent for study participation

Exclusion criteria

Exclusion criteria: Intake of ACE inhibitors Uncontrolled diabetes mellitus and hypertension Tuberculosis of spine Malignancy of spine or other organs Fracture related to spine Anemia (hemoglobin % Patients contraindicated for basti.

Design outcomes

Primary

Measure	Time frame
Variations in Angiotensin Converting Enzyme level testTimepoint: At baseline and on 5th day in control group. At baseline, on 5th day and on 22nd day in intervention group	—

Secondary

Measure	Time frame
Relief in signs and symptoms and improvement in quality of lifeTimepoint: Within 2 year from the trial	—

Countries

India

Contacts

Public ContactDr Anup B Thakar

Institute for Post Graduate Training and Research in Ayurveda

anup_thakar@yahoo.com9978403323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026